k Repaglinide antidiabetic drug action, illustration Illustration showing repaglinide yellow, white, blue and red spheres, centreleft and centreright binding to an ATPdependent potassium channel multicoloured globularhelical structures on a pancreatic beta cell. Repaglinide belongs to a class of drugs known as meglitinides which bind to this type of receptor on pancreatic beta cells, stimulating insulin release. Insulin, in turn, increases cellular glucose uptake, reducing blood sugar levels, making repaglinide a suitable treatment for type 2 diabetes., by RAMON ANDRADE 3DCIENCIASCIENCE PHOTO LIBRARY Stock Photo - Afloimages
Sign up
Login
All images
Repaglinide antidiabetic drug action, illustration Illustration showing repaglinide  yellow, white, blue and red spheres, centre left and centre right  binding to an ATP dependent potassium channel  multicoloured globular helical structures  on a pancreatic beta cell. Repaglinide belongs to a class of drugs known as meglitinides which bind to this type of receptor on pancreatic beta cells, stimulating insulin release. Insulin, in turn, increases cellular glucose uptake, reducing blood sugar levels, making repaglinide a suitable treatment for type 2 diabetes., by RAMON ANDRADE 3DCIENCIA SCIENCE PHOTO LIBRARY
RM

Repaglinide antidiabetic drug action, illustration

Illustration showing repaglinide (yellow, white, blue and red spheres, centre-left and centre-right) binding to an ATP-dependent potassium channel (multicoloured globular/helical structures) on a pancreatic beta cell. Repaglinide belongs to a class of drugs known as meglitinides which bind to this type of receptor on pancreatic beta cells, stimulating insulin release. Insulin, in turn, increases cellular glucose uptake, reducing blood sugar levels, making repaglinide a suitable treatment for type 2 diabetes., by RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY

Details

ID
250409328

Collection

License type
Rights Managed

Photographer



Sign in
Member access
Login not found.